Genetic variations of HSD11B2 in hypertensive patients and in the general population, six rare missense/frameshift mutations

Hypertension Research

Volumn 29, Issue 4, 2006, Pages 243-252

  Kamide, Kei ^a   Kokubo, Yoshihiro ^a   Hanada, Hironori ^a   Nagura, Junko ^a   Yang, Jin ^a   Takiuchi, Shin ^a   Tanaka, Chihiro ^a   Banno, Mariko ^a   Miwa, Yoshikazu ^a   Yoshii, Masayoshi ^a   Matayoshi, Tetsutaro ^a   Yasuda, Hisayo ^a   Horio, Takeshi ^a   Okayama, Akira ^a   Tomoike, Hitonobu ^a   Kawano, Yuhei ^a   Miyata, Toshiyuki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Essential hypertension; Genetic variation; HSD11B2; Missense mutation; Salt sensitivity

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROMOTER REGION; SEQUENCE ANALYSIS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; AGED; AMINO ACID SEQUENCE; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; FEMALE; FRAMESHIFT MUTATION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; VARIATION (GENETICS);

EID: 33744948083     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.243     Document Type: Article

References (37)

1. Agarwal AK, Monder C, Eckstein B, et al: Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. J Biol Chem 1989; 264: 18939-18943.
2. Albiston AL, Obeyesekere VR, Smith RE, et al: Cloning and tissue distribution of the human 11beta-hydroxysteroid dehydrogenase type 2 enzyme. Mol Cell Endocrinol 1994; 105: R11-R17.
3. Tannin GM, Agarwal AK, Monder C, et al: The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J Biol Chem 1991; 266: 16653-16658.
4. +-dependent isoform of 11beta-hydroxysteroid dehydrogenase in sheep kidney. Endocr Res 1995; 21: 389-397.
5. +-dependent isoform of 11beta-hydroxysteroid dehydrogenase. Endocrinology 1992; 131: 970-972.
6. New MI, Levine LS, Biglieri EG, et al: Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 1977; 44: 924-933.
7. Geller DS: A mineralocorticoid receptor mutation causing human hypertension. Curr Opin Nephrol Hypertens 2001; 10: 661-665.
8. Ferrari P: Genetics of the mineralocorticoid system in primary hypertension. Curr Hypertens Rep 2002; 4: 18-24.
9. Dave-Sharma S, Wilson RC, Harbison MD, et al: Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1998; 83: 2244-2254.
10. Ferrari P, Krozowski Z: Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation. Kidney Int 2000; 57: 1374-1381.
11. Ferrari P, Lovati E, Frey FJ: The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. J Hypertens 2000; 18: 241-248.
12. Mune T, Rogerson FM, Nikkila H, et al: Human hypertension caused by mutations in the kidney isozyme of 11beta-hydroxysteroid dehydrogenase. Nat Genet 1995; 10: 394-399.
13. Li A, Tedde R, Krozowski ZS, et al: Molecular basis for hypertension in the "type II variant" of apparent mineralocorticoid excess. Am J Hum Genet 1998; 63: 370-379.
14. Nunez BS, Rogerson FM, Mune T, et al: Mutants of 11beta-hydroxysteroid dehydrogenase (11-HSD2) with partial activity: improved correlations between genotype and biochemical phenotype in apparent mineralocorticoid excess. Hypertension 1999; 34: 638-642.
15. Odermatt A, Dick B, Arnold P, et al: A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension. J Clin Endocrinol Metab 2001; 86: 1247-1252.
16. Lavery GG, Ronconi V, Draper N, et al: Late-onset apparent mineralocorticoid excess caused by novel compound heterozygous mutations in the HSD11B2 gene. Hypertension 2003; 42: 123-129.
17. Quinkler M, Bappal B, Draper N, et al: Molecular basis for the apparent mineralocorticoid excess syndrome in the Oman population. Mol Cell Endocrinol 2004; 217: 143-149.
18. Kitanaka S, Katsumata N, Tanae A, et al: A new compound heterozygous mutation in the 11beta-hydroxysteroid dehydrogenase type 2 gene in a case of apparent mineralocorticoid excess. J Clin Endocrinol Metab 1997; 82: 4054-4058.
19. Wilson RC, Nimkarn S, New MI: Apparent mineralocorticoid excess. Trends Endocrinol Metab 2001; 12: 104-111.
20. Ugrasbul F, Wiens T, Rubinstein P, et al: Prevalence of mild apparent mineralocorticoid excess in Mennonites. J Clin Endocrinol Metab 1999; 84: 4735-4738.
21. Brand E, Chatelain N, Mulatero P, et al: Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension 1998; 32: 198-204.
22. Smolenicka Z, Bach E, Schaer A, et al: A new polymorphic restriction site in the human 11beta-hydroxysteroid dehydrogenase type 2 gene. J Clin Endocrinol Metab 1998; 83: 1814-1817.
23. Lovati E, Ferrari P, Dick B, et al: Molecular basis of human salt sensitivity: the role of the 11beta-hydroxysteroid dehydrogenase type 2. J Clin Endocrinol Metab 1999; 84: 3745-3749.
24. Kamide K, Takiuchi S, Tanaka C, et al: Three novel missense mutations of WNK4, a kinase mutated in inherited hypertension, in Japanese hypertensives: implication of clinical phenotypes. Am J Hypertens 2004; 17: 446-449.
25. Kamide K, Tanaka C, Takiuchi S, et al: Six missense mutations of the epithelial sodium channel beta and gamma subunits in Japanese hypertensives. Hypertens Res 2004; 27: 333-338.
26. Kamide K, Yang J, Kokubo Y, et al: A novel missense mutation, F826Y, in the mineralocorticoid receptor gene in Japanese hypertensives: implication of clinical phenotypes. Hypertens Res 2005; 28: 703-709.
27. - cotransporter gene, C1784T, and adrenergic receptor-β3 gene, T727C, may be gene polymorphisms susceptible to the antihypertensive effect of thiazide diuretics. Hypertens Res 2004; 27: 821-833.
28. Takiuchi S, Mannami T, Miyata T, et al: Identification of 21 single nucleotide polymorphisms in human hepatocyte growth factor gene and association with blood pressure and carotid atherosclerosis in the Japanese population. Atherosclerosis 2004; 173: 301-307.
29. Kokubo Y, Inamoto N, Tomoike H, et al: Association of genetic polymorphisms of sodium-calcium exchanger 1 gene, NCX1, with hypertension in a Japanese general population. Hypertens Res 2004; 27: 697-702.
30. Tanaka C, Mannami T, Kamide K, et al: Single nucleotide polymorphisms in the interleukin-6 gene associated with blood pressure and atherosclerosis in a Japanese general population. Hypertens Res 2005; 28: 35-41.
31. Tanaka C, Kamide K, Takiuchi S, et al: An alternative fast and convenient genotyping method for the screening of angiotensin converting enzyme gene polymorphisms. Hypertens Res 2003; 26: 301-306.
32. Wilson RC, Dave-Sharma S, Wei JQ, et al: A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci U S A 1998; 95: 10200-10205.
33. Cohen JC, Kiss RS, Pertsemlidis A, et al: Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004; 305: 869-872.
34. Yang J, Kamide K, Kokubo Y, et al: Genetic variations of regulator of G-protein signaling 2 in hypertensive patients and in the general population. J Hypertens 2005; 23: 1497-1505.
35. +-dependent isoform of 11beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. J Biol Chem 1994; 269: 25959-25962.
36. Zaehner T, Plueshke V, Frey BM, et al: Structural analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene in end-stage renal disease. Kidney Int 2000; 58: 1413-1419.
37. Antonarakis SE, Nomenclature Working Group: Recommendations for a nomenclature system for human gene mutations. Hum Mut 1998; 11: 1-3.